Daily pill lowered blood sugar levels by an average of 1.3%, Lilly says In trial, Type 2 diabetes patients lost nearly 8% of their body weight Company confident pill could launch worldwide without ...

FRIDAY, April 18, 2025 (HealthDay News) — A new pill designed to help with weight loss and blood sugar control is showing promise in early studies. Eli Lilly said its experimental drug ...

Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced success Thursday of its Phase 3 clinical trial for a once-daily GLP-1 pill — an oral form of the blockbuster medication used for ...

Add articles to your saved list and come back to them any time. Pharmaceutical company Eli Lilly said its experimental pill worked as well as blockbuster drug Ozempic to lower weight and blood ...

The first daily weight-loss pill is expected to be available in the UK as soon as 2026 after a trial found it to be effective in treating obesity and diabetes. The drug, developed by Eli Lilly and ...

Eli Lilly & Co. plans to manufacture its new weight-loss pill in the US for patients around the world as President Donald Trump presses companies to move production back to American shores.

9NEWS Health Expert Dr. Payal Kohli talks about the new drug that Eli Lilly says can lower blood sugar levels and induce weight loss in people with Type 2 diabetes. Three ex-presidents denounce ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Eli Lilly’s new obesity and diabetes pill has shown it can lower blood sugar and aid weight loss in a ...

And on the wedding day, they made sure to match that energy with their looks. Dressed in matching pink laces and striped pink-and-white asooke geles, they brought a strong, unified presence that ...

A daily GLP-1 pill can help people with type 2 diabetes regulate their blood sugar and lose weight, drugmaker Eli Lilly announced on Thursday. The readout comes just days after Pfizer announced it ...

President Trump's new tariffs are the largest in a century and treat some adversaries better than America's allies. Photo: Mandel Nganpedro Pardo/AFP/Getty Images A supply chain is only as strong ...

Eli Lilly announced Thursday the successful completion of a phase 3 trial of Orforglipron – the first small-molecule GLP-1 that is administered as a once-daily oral pill. The ACHIEVE-1 trial ...